Article
Low-dose interleukin-2 for recurrent early pregnancy loss: a proof-of-concept study
2025-06-16
Abstract excerpt
<h4>Background</h4> Regulatory T cells (Tregs) are essential for maternal-fetal tolerance, and their deficiency has been implicated in immune-mediated pregnancy loss. Low-dose interleukin-2 (IL-2 LD ) selectively expands and activates Tregs and has shown efficacy in murine models of spontaneous immune-mediated miscarriage. This proof-of-concept study assessed the safety and efficacy of IL-2 LD in women with une...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- de89c576-4dcb-5c51-aeb5-d50863eeab9b
- DOI
- 10.1101/2025.06.13.25328550
